Artiva Biotherapeutics Competitors and Similar CompaniesClear all

Artiva Biotherapeutics's competitors and similar companies include Immutep, OncoTherapy Science, Bexion Pharmaceuticals and Numab.

	Artiva Biotherapeutics Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors.	Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.	Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.	Numab Numab Therapeutics is an oncology-focused biopharmaceutical company.
Founding Date	Founding Date 2019	Founding Date 2001	Founding Date 2001	Founding Date 2006	Founding Date 2011
Type	Type Public	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations San Diego, US HQ	Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE	Locations Kawasaki, JP HQ	Locations Covington, US HQ	Locations Wädenswil, CH HQ
Employees	Employees 81	Employees 2427% decrease	Employees 54	Employees 274% increase	Employees 681% decrease
Valuation ($)	Valuation ($) 263.8 m	Valuation ($) 282.4 m	Valuation ($) 56.9 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥808.5m (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥794.6m (FY, 2026)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $5m (FY, 2025)	Gross profit ¥14m (FY, 2026)	Gross profit N/A	Gross profit N/A
Net income	Net income ($83.9m) (FY, 2025)	Net income ($61.4m) (FY, 2025)	Net income (¥910.6m) (FY, 2026)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 16.6m (about 7 years ago)	Latest funding round $ 110m (about 5 years ago)
Total funding raised	Total funding raised $ 78m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 16.6m	Total funding raised $ 132.3m